DE69031996T2 - Menschlicher rekombinanter plazentaler ribonuklease-inhibitor und verfahren zur herstellung - Google Patents

Menschlicher rekombinanter plazentaler ribonuklease-inhibitor und verfahren zur herstellung

Info

Publication number
DE69031996T2
DE69031996T2 DE69031996T DE69031996T DE69031996T2 DE 69031996 T2 DE69031996 T2 DE 69031996T2 DE 69031996 T DE69031996 T DE 69031996T DE 69031996 T DE69031996 T DE 69031996T DE 69031996 T2 DE69031996 T2 DE 69031996T2
Authority
DE
Germany
Prior art keywords
ribonuclease inhibitor
placental ribonuclease
human placental
production
human recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69031996T
Other languages
English (en)
Other versions
DE69031996D1 (de
Inventor
Martin Lewis
John Shultz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Promega Corp
Original Assignee
Promega Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Promega Corp filed Critical Promega Corp
Application granted granted Critical
Publication of DE69031996D1 publication Critical patent/DE69031996D1/de
Publication of DE69031996T2 publication Critical patent/DE69031996T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69031996T 1989-04-24 1990-04-18 Menschlicher rekombinanter plazentaler ribonuklease-inhibitor und verfahren zur herstellung Expired - Fee Related DE69031996T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34236289A 1989-04-24 1989-04-24
PCT/US1990/002122 WO1990012881A1 (en) 1989-04-24 1990-04-18 Human recombinant placental ribonuclease inhibitor and method of production

Publications (2)

Publication Number Publication Date
DE69031996D1 DE69031996D1 (de) 1998-03-05
DE69031996T2 true DE69031996T2 (de) 1998-06-10

Family

ID=23341508

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69031996T Expired - Fee Related DE69031996T2 (de) 1989-04-24 1990-04-18 Menschlicher rekombinanter plazentaler ribonuklease-inhibitor und verfahren zur herstellung

Country Status (8)

Country Link
EP (1) EP0422217B1 (de)
JP (2) JP3009458B2 (de)
AT (1) ATE162853T1 (de)
AU (1) AU646803B2 (de)
DE (1) DE69031996T2 (de)
DK (1) DK0422217T3 (de)
ES (1) ES2111537T3 (de)
WO (1) WO1990012881A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0291686B1 (de) * 1987-04-14 1993-10-13 The President And Fellows Of Harvard College Angiogenininhibitoren
US7560248B1 (en) 1999-01-20 2009-07-14 Wisconsin Alumni Research Foundation Oxidation-resistant ribonuclease inhibitor
WO2001004307A1 (en) * 1999-07-13 2001-01-18 Zymogenetics, Inc. Alpha protein - 27
DE102005015005A1 (de) * 2005-04-01 2006-10-05 Qiagen Gmbh Verfahren zur Behandlung einer Biomoleküle enthaltenden Probe
GB201101794D0 (en) * 2011-02-02 2011-03-16 Fermentas Uab Protein production
PL436077A1 (pl) * 2020-11-25 2022-05-30 Blirt Spółka Akcyjna Liofilizowany i gotowy do liofilizacji rekombinowany ludzki inhibitor RNaz

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0291686B1 (de) * 1987-04-14 1993-10-13 The President And Fellows Of Harvard College Angiogenininhibitoren

Also Published As

Publication number Publication date
WO1990012881A1 (en) 1990-11-01
EP0422217B1 (de) 1998-01-28
DK0422217T3 (da) 1998-03-02
AU5537790A (en) 1990-11-16
JP3009458B2 (ja) 2000-02-14
EP0422217A4 (en) 1992-08-19
ES2111537T3 (es) 1998-03-16
ATE162853T1 (de) 1998-02-15
AU646803B2 (en) 1994-03-10
JPH03505677A (ja) 1991-12-12
EP0422217A1 (de) 1991-04-17
JP3366596B2 (ja) 2003-01-14
JP2000078992A (ja) 2000-03-21
DE69031996D1 (de) 1998-03-05

Similar Documents

Publication Publication Date Title
NO179253C (no) Rekombinant DNA-sekvens som koder for humant proapolipoprotein A-I, ekspresjonsvektorer, cellekulturer samt fremgangsmåte for fremstilling av proteinet
DE3586189D1 (de) Menge und verfahren zur herstellung rekombinierter erzeugnisse in grosser ausbeute.
IE811463L (en) Interferons
EP0722461A4 (de) Expression eines fusionspolypeptides, das ohne leadersequenz aus dem cytoplasma transportiert wird
DE69930955D1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
EP0048970A3 (de) Polypeptide, Verfahren zu ihrer mikrobischen Herstellung, Zwischenprodukte dafür und diese enthaltende Zusammensetzungen
DE60033138D1 (de) Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren
ATE5001T1 (de) Verfahren zur herstellung eines ausgewaehlten proteins.
DE69839553D1 (de) Verfahren zur herstellung von proteinen
BR8301918A (pt) Proteina,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,composicao,cultura de celulas,utilizacao de tal proteina,processo de expressao,processo para producao de um veiculo de expressao e processo para preparacao de uma proteina uroquinase
DE69332520T2 (de) Nukleinsäure, expressionsvektor und zusammensetzungen zur identifizierung und herstellung von rekombinanten sialyltransferasen
DE69329195D1 (de) Rekombinante dna moleküle die aminopeptidase enzyme kodieren und ihre anwendung für die herstellung von impfstoffen gegen helminth infektionen
DE69031996D1 (de) Menschlicher rekombinanter plazentaler ribonuklease-inhibitor und verfahren zur herstellung
EP0072541A3 (de) Menschliche Leukozyten-Interferone, Verfahren zu deren Mikrobiologischer Herstellung, Zwischenprodukte und diese enthaltende Zusammensetzungen
ATE145004T1 (de) Verfahren zur herstellung von luciferase durch rekombinante expression eines luciferase- kodierenden gens
ATE43139T1 (de) Klonierungs- und expressionsvektoren fuer gammainterferon, transformierte bakterien und verfahren zur herstellung von gamma-interferon.
DE68920321T2 (de) Verfahren zur herstellung eines menschlichen "neutrophil chemotactic factor"-polypeptids.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee